Zobair M Younossi (Z Younossi, Z M Younossi, Zobair Younossi)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 119

Top Venues

Alimentary pharmacology & therapeutics

Hepatology communications

Liver international : official journal of the International Association for the Study of the Liver

Hepatology (Baltimore, Md.)

This page only lists publications with an associated author ORCID identifier.

Publications

Linda Henry, Zobair M Younossi
Letter: should we abandon FIB-4 to characterise noninvasively patients with NAFLD? Authors' reply. Alimentary pharmacology & therapeutics 57 (8) (2023)
Zobair M Younossi, Shira Zelber-Sagi, Linda Henry, Lynn H Gerber
Lifestyle interventions in nonalcoholic fatty liver disease. Nature reviews. Gastroenterology & hepatology (2023)
Maria Stepanova, Zobair M Younossi
Editorial: optimal combination of non-invasive tests to determine significant fibrosis in non-alcoholic fatty liver disease-authors' reply. Alimentary pharmacology & therapeutics 57 (12) (2023)
Zobair M Younossi, Ming-Lung Yu, Yusuf Yilmaz, Khalid Aida Alswat, Maria Buti, Marlen Ivon Castellanos Fernandez, Georgios Papatheodoridis, Saeed S Hamid, Mohamed El Kassas, Wah Kheong Chan, Ajay K Duseja, Stuart C Gordon, Yuichiro Eguchi, Vasily A Isakov, Stuart Keith Roberts, Jian-Gao Fan, Ashwani K Singal, Manuel Romero-Gómez, Andrew A Li, Janus Ong, Brian P Lam, Issah Younossi, Fatema Nader, Andrei Racila, Maria Stepanova, Saleh Alqahtani
Clinical and Patient-Reported Outcome Profile of Patients with Hepatitis B Viral Infection from the Global Liver Registry™. Journal of viral hepatitis (2023)
Austin Henry, James M Paik, Patrick Austin, Katherine Elizabeth Eberly, Pegah Golabi, Issah Younossi, Linda Henry, N Lynn Gerber, Zobair M Younossi
Editorial: let's get physical-long-term benefits of vigorous physical activity in patients with nonalcoholic fatty liver disease. Authors' reply. Alimentary pharmacology & therapeutics 57 (6) (2023)
Zobair M Younossi, Ming-Lung Yu, Yusuf Yilmaz, Khalid Aida Alswat, Maria Buti, Marlen Ivon Castellanos Fernandez, Georgios Papatheodoridis, Saeed S Hamid, Mohamed El Kassas, Wah Kheong Chan, Ajay K Duseja, Stuart C Gordon, Yuichiro Eguchi, Vasily A Isakov, Stuart Keith Roberts, Jian-Gao Fan, Ashwani K Singal, Manuel Romero-Gómez, Andrew A Li, Janus Ong, Brian P Lam, Issah Younossi, Fatema Nader, Andrei Racila, Maria Stepanova, Saleh Alqahtani
Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™. Journal of viral hepatitis 30 (4) (2023)
Stephen A Harrison, Vlad Ratziu, Quentin Mark Anstee, Mazen Noureddin, Arun J Sanyal, Jörn Markus Schattenberg, Pierre Bedossa, Mustafa R Bashir, David Schneider, Rebecca Taub, Meena Bansal, Kris V Kowdley, Zobair M Younossi, Rohit Loomba
Design of the phase 3 MAESTRO clinical program to evaluate resmetirom for the treatment of nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics (2023)
Zobair M Younossi, Ming-Lung Yu, Yusuf Yilmaz, Khalid Aida Alswat, Maria Buti, Marlen Ivon Castellanos Fernandez, Georgios Papatheodoridis, Saeed S Hamid, Mohamed El Kassas, Wah Kheong Chan, Ajay K Duseja, Stuart C Gordon, Yuichiro Eguchi, Vasily A Isakov, Stuart Keith Roberts, Jian-Gao Fan, Ashwani K Singal, Manuel Romero-Gómez, Andrew A Li, Janus Ong, Brian P Lam, Issah Younossi, Fatema Nader, Andrei Racila, Maria Stepanova, Saleh Alqahtani
Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™. Journal of viral hepatitis (2023)
Marcelo Kugelmas, Mazen Noureddin, Nadege Gunn, Kimberly Brown, Zobair M Younossi, Manal Abdelmalek, Naim Alkhouri
The Use of Current Knowledge and Non-Invasive Testing Modalities for Predicting At-Risk Nonalcoholic Steatohepatitis and Assessing Fibrosis. Liver international : official journal of the International Association for the Study of the Liver (2023)
Maria Stepanova, Ameeta Kumar, Pamela Brandt, Nagashree Gundurao, Kenneth Cusi, Saleh Al Qahtani, Zobair M Younossi
Impact of Type 2 Diabetes on the Outcomes of Solid Organ Transplantations in the U.S.: Data From a National Registry. Diabetes care (2023)
Zobair M Younossi, Ming-Lung Yu, Yusuf Yilmaz, Khalid Aida Alswat, Maria Buti, Marlen Ivon Castellanos Fernandez, Georgios Papatheodoridis, Saeed S Hamid, Mohamed El Kassas, Wah Kheong Chan, Ajay K Duseja, Stuart C Gordon, Yuichiro Eguchi, Vasily A Isakov, Stuart Keith Roberts, Jian-Gao Fan, Ashwani K Singal, Manuel Romero-Gómez, Andrew A Li, Janus Ong, Brian P Lam, Issah Younossi, Fatema Nader, Andrei Racila, Maria Stepanova, Saleh Alqahtani
Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™. Journal of viral hepatitis 30 (4) (2023)
Zobair M Younossi, Ming-Lung Yu, Yusuf Yilmaz, Khalid Aida Alswat, Maria Buti, Marlen Ivon Castellanos Fernandez, Georgios Papatheodoridis, Saeed S Hamid, Mohamed El Kassas, Wah Kheong Chan, Ajay K Duseja, Stuart C Gordon, Yuichiro Eguchi, Vasily A Isakov, Stuart Keith Roberts, Jian-Gao Fan, Ashwani K Singal, Manuel Romero-Gómez, Andrew A Li, Janus Ong, Brian P Lam, Issah Younossi, Fatema Nader, Andrei Racila, Maria Stepanova, Saleh Alqahtani
Clinical and patient-reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™. Journal of viral hepatitis 30 (4) (2023)
Zobair M Younossi, Maria Stepanova, Sean Felix, Thomas Jeffers, Elena Younossi, Zachary Goodman, Andrei Racila, Brian P Lam, Linda Henry
The combination of the enhanced liver fibrosis and FIB-4 scores to determine significant fibrosis in patients with nonalcoholic fatty liver disease. Alimentary pharmacology & therapeutics (2023)
Heiner Wedemeyer, Tammo L Tergast, Jeffrey Victor Lazarus, Homie Razavi, Kostas Bakoyannis, Ricardo Baptista-Leite, Marco Bartoli, Philip Bruggmann, Cristian-Silviu Buşoi, Maria Buti, Manuel Carballo, Laurent Castera, Massimo Colombo, Rodrigo Sousa Coutinho, Yuval Dadon, Gamal Esmat, Rafael Esteban, Joan Colom Farran, Mark Gillyon-Powell, David Goldberg, Sharon Hutchinson, Harry L A Janssen, George Kalamitsis, Loreta A Kondili, John S Lambert, Rui Tato Marinho, Mojca Maticic, Aldo Patricello, Markus Peck-Radosavljevic, Stanislas Pol, Mario Poljak, Cora Pop, Tomislov Sokol, Vana Sypsa, Nurdan Tözün, Zobair M Younossi, Alessio Aghemo, Georgios Papatheodoridis, Angelos Hatzakis
Securing Wider EU Commitment to the Elimination of HCV. Liver international : official journal of the International Association for the Study of the Liver (2022)
Zobair M Younossi, Naim Alkhouri, Kenneth Cusi, Scott Isaacs, Fasiha Kanwal, Mazen Noureddin, Stephen Caldwell, Natarajan Ravendhran, Brian Lam, Khalil Nader, Andrei Racila, Fatema Nader, Linda Henry
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics 57 (3) (2022)
Zobair M Younossi, Naim Alkhouri, Kenneth Cusi, Scott Issacs, Fasiha Kanwal, Mazen Noureddin, Stephen Caldwell, Natarajan Ravendhran, Brian Lam, Khalil Nader, Andrei Racila, Fatema Nader, Linda Henry
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics (2022)
Yusuf Yilmaz, Zobair M Younossi
Editorial: changes of health-related quality of life associated with hepatic disease severity and its improvement after treatment in NAFLD-authors' reply. Alimentary pharmacology & therapeutics 57 (2) (2022)
Zobair M Younossi, James M Paik, Pegah Golabi, Youssef Younossi, Linda Henry, Fatema Nader
The impact of fatigue on mortality of patients with non-alcoholic fatty liver disease: Data from National Health and nutrition examination survey 2005-2010 and 2017-2018. Liver international : official journal of the International Association for the Study of the Liver 42 (12) (2022)
Austin Henry, James M Paik, Patrick Austin, Katherine Elizabeth Eberly, Pegah Golabi, Issah Younossi, Linda Henry, Lynn Gerber, Zobair M Younossi
Vigorous physical activity provides protection against all-cause deaths among adults patients with nonalcoholic fatty liver disease (NAFLD). Alimentary pharmacology & therapeutics (2022)
Stephen Caldwell, Daniel Q Huang, Arun J Sanyal, Quentin Mark Anstee, Michael Trauner, Eric J Lawitz, Dora Ding, Lily Ma, Catherine Jia, Andrew Billin, Ryan S Huss, Chuhan Chung, Zachary Goodman, Vincent Wai-Sun Wong, Takeshi Okanoue, Manuel Romero-Gómez, Manal F Abdelmalek, Andrew Muir, Nezam Afdhal, Jaime Bosch, Stephen Harrison, Zobair M Younossi, Robert P Myers
Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis. Gut 72 (3) (2022)
Yusuf Yilmaz, Zobair M Younossi
Editorial: changes of health-related quality of life associated with hepatic disease severity and its improvement after treatment in NAFLD-authors' reply. Alimentary pharmacology & therapeutics 57 (2) (2022)
Zobair M Younossi, Ming-Lung Yu, Mohamed El Kassas, Gamal Esmat, Marlen I Castellanos Fernández, Maria Buti, Georgios Papatheodoridis, Yusuf Yilmaz, Vasily Isakov, Ajay Duseja, Nahum Méndez-Sánchez, Saeed Hamid, Stuart C Gordon, Manuel Romero-Gómez, Wah-Kheong Chan, Janus P Ong, Issah Younossi, Brain Lam, Mariam Ziayee, Fatema Nader, Andrei Racila, Linda Henry, Maria Stepanova, null null
Severe impairment of patient-reported outcomes in patients with chronic hepatitis C virus infection seen in real-world practices across the world: Data from the global liver registry. Journal of viral hepatitis 29 (11) (2022)
Linda Henry, James Paik, Zobair M Younossi
Review article: the epidemiologic burden of non-alcoholic fatty liver disease across the world. Alimentary pharmacology & therapeutics 56 (6) (2022)
Rish K Pai, Vipul Jairath, Malcolm Hogan, Guangyong Zou, Oyedele A Adeyi, Quentin Mark Anstee, Bashar A Aqel, Cynthia Behling, Elizabeth J Carey, Andrew D Clouston, Kathleen E Corey, Brian G Feagan, David E Kleiner, Christopher Ma, Stefanie C McFarlane, Mazen Noureddin, Vlad Ratziu, Mark A Valasek, Zobair M Younossi, Stephen A Harrison, Stephen Caldwell
Reliability of histologic assessment for NAFLD and development of an expanded NAFLD activity score. Hepatology (Baltimore, Md.) 76 (4) (2022)
Zobair M Younossi, Yusuf Yilmaz, Mohamed El Kassas, Ajay Kumar Duseja, Saeed Hamid, Gamal Esmat, Nahum Méndez-Sánchez, Wah Kheong Chan, Ashwani K Singal, Brian Lam, Sean Felix, Elena Younossi, Manisha Verma, Jillian K Price, Fatema Nader, Issah Younossi, Andrei Racila, Maria Stepanova
The impact of the COVID-19 pandemic on patients with chronic liver disease: Results from the Global Liver Registry. Hepatology communications 6 (10) (2022)
Brian Lam, Maria Stepanova, Chapy Venkatesan, Ivan Garcia, Mary Reyes, Ashiq Mannan, Soleyah Groves, Mehul Desai, Andrei Racila, Andrej Kolacevski, Linda Henry, Lynn H Gerber, Zobair M Younossi
Outcomes of hospitalized patients with COVID-19 during the course of the pandemic in a fully integrated health system. PloS one 17 (2) (2022)
Zobair M Younossi, James M Paik, Reem Al Shabeeb, Pegah Golabi, Issah Younossi, Linda Henry
Are there outcome differences between NAFLD and metabolic-associated fatty liver disease? Hepatology (Baltimore, Md.) 76 (5) (2022)
Catherine Van Dongen, James M Paik, Michael Harring, Youssef Younossi, Jillian K Price, Khaled Kabbara, Pegah Golabi, Zobair M Younossi
Sarcopenia, healthy living, and mortality in patients with chronic liver diseases. Hepatology communications 6 (11) (2022)
Stephen Caldwell, Daniel Q Huang, Arun J Sanyal, Quentin Mark Anstee, Michael Trauner, Eric J Lawitz, Dora Ding, Lily Ma, Catherine Jia, Andrew Billin, Ryan S Huss, Chuhan Chung, Zachary Goodman, Vincent Wai-Sun Wong, Takeshi Okanoue, Manuel Romero-Gómez, Manal F Abdelmalek, Andrew Muir, Nezam Afdhal, Jaime Bosch, Stephen Harrison, Zobair M Younossi, Robert P Myers
Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis. Gut 72 (3) (2022)
Linda Henry, James M Paik, Zobair M Younossi
Reply. Hepatology (Baltimore, Md.) 76 (5) (2022)
Zobair M Younossi, Naim Alkhouri, Kenneth Cusi, Scott Isaacs, Fasiha Kanwal, Mazen Noureddin, Stephen Caldwell, Natarajan Ravendhran, Brian Lam, Khalil Nader, Andrei Racila, Fatema Nader, Linda Henry
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics 57 (3) (2022)
Stephen Caldwell, Daniel Q Huang, Arun J Sanyal, Quentin Mark Anstee, Michael Trauner, Eric J Lawitz, Dora Ding, Lily Ma, Catherine Jia, Andrew Billin, Ryan S Huss, Chuhan Chung, Zachary Goodman, Vincent Wai-Sun Wong, Takeshi Okanoue, Manuel Romero-Gómez, Manal F Abdelmalek, Andrew Muir, Nezam Afdhal, Jaime Bosch, Stephen Harrison, Zobair M Younossi, Robert P Myers
Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis. Gut 72 (3) (2022)
Maria Stepanova, Khaled Kabbara, Denise Mohess, Manisha Verma, Alva Roche-Green, Saleh AlQahtani, Janus Ong, Patrizia Burra, Zobair M Younossi
Nonalcoholic steatohepatitis is the most common indication for liver transplantation among the elderly: Data from the United States Scientific Registry of Transplant Recipients. Hepatology communications 6 (7) (2022)
Zobair M Younossi, Naim Alkhouri, Kenneth Cusi, Scott Isaacs, Fasiha Kanwal, Mazen Noureddin, Stephen Caldwell, Natarajan Ravendhran, Brian Lam, Khalil Nader, Andrei Racila, Fatema Nader, Linda Henry
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics (2022)
Zobair M Younossi, Naim Alkhouri, Kenneth Cusi, Scott Isaacs, Fasiha Kanwal, Mazen Noureddin, Stephen Caldwell, Natarajan Ravendhran, Brian Lam, Khalil Nader, Andrei Racila, Fatema Nader, Linda Henry
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics 57 (3) (2022)
Yusuf Yilmaz, Ahmet Eren Toraman, Ceyda Alp, Zehra Doğan, Caglayan Keklikkiran, Maria Stepanova, Zobair M Younossi
Impairment of patient-reported outcomes among patients with non-alcoholic fatty liver disease: a registry-based study. Alimentary pharmacology & therapeutics (2022)
Zobair M Younossi, Naim Alkhouri, Kenneth Cusi, Scott Isaacs, Fasiha Kanwal, Mazen Noureddin, Stephen Caldwell, Natarajan Ravendhran, Brian Lam, Khalil Nader, Andrei Racila, Fatema Nader, Linda Henry
A practical use of noninvasive tests in clinical practice to identify high-risk patients with nonalcoholic steatohepatitis. Alimentary pharmacology & therapeutics 57 (3) (2022)
Stephen Caldwell, Daniel Q Huang, Arun J Sanyal, Quentin Mark Anstee, Michael Trauner, Eric J Lawitz, Dora Ding, Lily Ma, Catherine Jia, Andrew Billin, Ryan S Huss, Chuhan Chung, Zachary Goodman, Vincent Wai-Sun Wong, Takeshi Okanoue, Manuel Romero-Gómez, Manal F Abdelmalek, Andrew Muir, Nezam Afdhal, Jaime Bosch, Stephen Harrison, Zobair M Younossi, Robert P Myers
Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis. Gut 72 (3) (2022)
Khaled Kabarra, Pegah Golabi, Zobair M Younossi
Nonalcoholic steatohepatitis: global impact and clinical consequences. Endocrine connections 10 (10) (2021)
James M Paik, Pegah Golabi, Youssef Younossi, Nazaneen Saleh, Annan Nhyira, Zobair M Younossi
The Growing Burden of Disability Related to Chronic Liver Disease in the United States: Data From the Global Burden of Disease Study 2007-2017. Hepatology communications 5 (5) (2021)
Zobair M Younossi, Maria Stepanova, Brian Lam, Rebecca Cable, Sean Felix, Thomas Jeffers, Elena Younossi, Huong Pham, Manirath Srishord, Patrick Austin, Michael Estep, Kathy Terra, Carey Escheik, Leyla de Avila, Pegah Golabi, Andrej Kolacevski, Andrei Racila, Linda Henry, Lynn Gerber
Independent Predictors of Mortality Among Patients With NAFLD Hospitalized With COVID-19 Infection. Hepatology communications (2021)
Zobair M Younossi, Mary E Rinella, Arun J Sanyal, Stephen A Harrison, Elizabeth M Brunt, Zachary Goodman, David E Cohen, Rohit Loomba
From NAFLD to MAFLD: Implications of a Premature Change in Terminology. Hepatology (Baltimore, Md.) 73 (3) (2021)
Saleh A Alqahtani, James M Paik, Rakesh Biswas, Tamoore Arshad, Linda Henry, Zobair M Younossi
Poor Awareness of Liver Disease Among Adults With NAFLD in the United States. Hepatology communications 5 (11) (2021)
John Paul Verderese, Maria Stepanova, Brian Lam, Andrei Racila, Andrej Kolacevski, David Allen, Erin Hodson, Bahareh Aslani-Amoli, Michael Homeyer, Sarah Stanmyre, Helen Stevens, Stephanie Garofalo, Linda Henry, Chapy Venkatesan, Lynn H Gerber, Steve Motew, J Stephen Jones, Zobair M Younossi
Neutralizing Monoclonal Antibody Treatment Reduces Hospitalization for Mild and Moderate COVID-19: A Real-World Experience. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
Zobair M Younossi, Maria Stepanova, Mazen Noureddin, Kris V Kowdley, Simone I Strasser, Anita Kohli, Peter Ruane, Mitchell L Shiffman, Aasim Sheikh, Nadege Gunn, Stephen H Caldwell, Ryan S Huss, Robert P Myers, Vincent Wai-Sun Wong, Naim Alkhouri, Zachary Goodman, Rohit Loomba
Improvements of Fibrosis and Disease Activity Are Associated With Improvement of Patient-Reported Outcomes in Patients With Advanced Fibrosis Due to Nonalcoholic Steatohepatitis. Hepatology communications 5 (7) (2021)
Joana Vieira Barbosa, Scott Milligan, Andrew Frick, Jeremy Broestl, Zobair M Younossi, Nezam H Afdhal, Michelle Lai
Fibrosis-4 Index as an Independent Predictor of Mortality and Liver-Related Outcomes in NAFLD. Hepatology communications 6 (4) (2021)
John Paul Verderese, Linda Henry, Zobair M Younossi
Reply to Bailly, et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2021)
Saleh A Alqahtani, Pegah Golabi, James M Paik, Brian Lam, Amir H Moazez, Hazem A Elariny, Zachary Goodman, Zobair M Younossi
Performance of Noninvasive Liver Fibrosis Tests in Morbidly Obese Patients with Nonalcoholic Fatty Liver Disease. Obesity surgery 31 (5) (2021)
James M Paik, Seema Mir, Saleh A Alqahtani, Youssef Younossi, Janus P Ong, Zobair M Younossi
Dietary Risks for Liver Mortality in NAFLD: Global Burden of Disease Data. Hepatology communications (2021)
Tamoore Arshad, James M Paik, Rakesh Biswas, Saleh A Alqahtani, Linda Henry, Zobair M Younossi
Nonalcoholic Fatty Liver Disease Prevalence Trends Among Adolescents and Young Adults in the United States, 2007-2016. Hepatology communications 5 (10) (2021)
Fasiha Kanwal, Jay H Shubrook, Zobair M Younossi, Yamini Natarajan, Elisabetta Bugianesi, Mary E Rinella, Stephen A Harrison, Christos S Mantzoros, Kim Pfotenhauer, Samuel Klein, Robert H Eckel, Davida Kruger, Hashem El-Serag, Kenneth Cusi
Preparing for the NASH Epidemic: A Call to Action. Diabetes care 44 (9) (2021)
Arun J Sanyal, Quentin Mark Anstee, Michael Trauner, Eric J Lawitz, Manal F Abdelmalek, Dora Ding, Ling Han, Catherine Jia, Ryan S Huss, Chuhan Chung, Vincent Wai-Sun Wong, Takeshi Okanoue, Manuel Romero-Gomez, Andrew J Muir, Nezam H Afdhal, Jaime Bosch, Zachary Goodman, Stephen A Harrison, Zobair M Younossi, Robert P Myers
Cirrhosis Regression is Associated with Improved Clinical Outcomes in Patients with Nonalcoholic Steatohepatitis. Hepatology (Baltimore, Md.) (2021)
James M Paik, Pegah Golabi, Youssef Younossi, Alita Mishra, Zobair M Younossi
Changes in the Global Burden of Chronic Liver Diseases From 2012 to 2017: The Growing Impact of NAFLD. Hepatology (Baltimore, Md.) 72 (5) (2020)
Pegah Golabi, James M Paik, Tamoore Arshad, Youssef Younossi, Alita Mishra, Zobair M Younossi
Mortality of NAFLD According to the Body Composition and Presence of Metabolic Abnormalities. Hepatology communications 4 (8) (2020)
Zobair M Younossi, Kathleen E Corey, Naim Alkhouri, Mazen Noureddin, Ira Jacobson, Brian Lam, Stephen Clement, Rita Basu, Stuart C Gordon, Natarajan Ravendhra, Puneet Puri, Mary Rinella, Peter Scudera, Ashwani K Singal, Linda Henry, null null
Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices. Alimentary pharmacology & therapeutics 52 (3) (2020)
Azza Karrar, Bijal Rajput, Siddharth Hariharan, Dinan Abdelatif, Mohamad Houry, Ali Moosvi, Irfan Ali, Daisong Tan, Sohailla Noor, Donna Esmaeili, Sean Felix, Lakshmi Alaparthi, Munkhzul Otgonsuren, Brian Lam, Zachary D Goodman, Zobair M Younossi
Major Histocompatibility Complex Class I-Related Chain A Alleles and Histology of Nonalcoholic Fatty Liver Disease. Hepatology communications 5 (1) (2020)
Zobair M Younossi, Maria Stepanova, Issah Younossi, Andrei Racila
Development and validation of a hepatitis B-specific health-related quality-of-life instrument: CLDQ-HBV. Journal of viral hepatitis 28 (3) (2020)
James M Paik, Pegah Golabi, Rakesh Biswas, Saleh Alqahtani, Chapy Venkatesan, Zobair M Younossi
Nonalcoholic Fatty Liver Disease and Alcoholic Liver Disease are Major Drivers of Liver Mortality in the United States. Hepatology communications 4 (6) (2020)
James M Paik, Pegah Golabi, Youssef Younossi, Manirath Srishord, Alita Mishra, Zobair M Younossi
The Growing Burden of Disability Related to Nonalcoholic Fatty Liver Disease: Data From the Global Burden of Disease 2007-2017. Hepatology communications 4 (12) (2020)
Zobair M Younossi, Vincent Wai-Sun Wong, Quentin Mark Anstee, Manuel Romero, Michael H Trauner, Stephen A Harrison, Eric J Lawitz, Takeshi Okanoue, Marianne Camargo, Kathryn Kersey, Robert P Myers, Zachary Goodman, Maria Stepanova
Fatigue and Pruritus in Patients with Advanced Fibrosis Due to Nonalcoholic Steatohepatitis: The Impact on Patient-Reported Outcomes. Hepatology communications 4 (11) (2020)
Zobair M Younossi, Lind Henry
Letter: the use of Fibrosis-4 score in primary care and diabetology practices-Occam's razor applied to advanced fibrosis screening. Authors' reply. Alimentary pharmacology & therapeutics 52 (11-12) (2020)
Elizabeth M Brunt, David E Kleiner, Danielle H Carpenter, Mary Rinella, Stephen A Harrison, Rohit L Loomba, Zobair M Younossi, Brent A Neuschwander-Tetri, Arun J Sanyal, null null
Nonalcoholic fatty liver disease: Reporting histologic findings in clinical practice. Hepatology (Baltimore, Md.) (2020)
Zobair M Younossi, Frank Tacke, Marco Arrese, Barjesh Chander Sharma, Ibrahim Mostafa, Elisabetta Bugianesi, Vincent Wai-Sun Wong, Yusuf Yilmaz, Jacob George, Jiangao Fan, Miriam B Vos
Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. Hepatology (Baltimore, Md.) 69 (6) (2020)
Zobair M Younossi, Linda Henry
Editorial: a diabetologist's perspective on the diagnosis and monitoring of NAFLD-Authors' reply. Alimentary pharmacology & therapeutics 52 (4) (2020)
Angelos Hatzakis, Jeffrey Victor Lazarus, Evangelos Cholongitas, Ricardo Baptista-Leite, Charles Boucher, Cristian-Silviu Busoi, Sylvie Deuffic-Burban, Jagpreet Chhatwal, Gamal Esmat, Sharon Hutchinson, Minerva-Melpomeni Malliori, Mojca Maticic, Antons Mozalevskis, Francesco Negro, George A Papandreou, Georgios Papatheodoridis, Markus Peck-Radosavljevic, Homie Razavi, Tatjana Reic, Eberhard Schatz, Nurdan Tozun, Zobair M Younossi, Michael P Manns
Securing sustainable funding for viral hepatitis elimination plans. Liver international : official journal of the International Association for the Study of the Liver 40 (2) (2019)
Zobair M Younossi, Radhika P Tampi, Andrei Racila, Ying Qiu, Leah Burns, Issah Younossi, Fatema Nader
Economic and Clinical Burden of Nonalcoholic Steatohepatitis in Patients With Type 2 Diabetes in the U.S. Diabetes care 43 (2) (2019)
Zobair M Younossi, Georgios Papatheodoridis, Patrice Cacoub, Francesco Negro, Heiner Wedemeyer, Linda Henry, Angelos Hatzakis
The comprehensive outcomes of hepatitis C virus infection: A multi-faceted chronic disease. Journal of viral hepatitis (2019)
Omer Shahab, Mehmet Sayiner, James Paik, Sean Felix, Pegah Golabi, Zobair M Younossi
Burden of Primary Biliary Cholangitis Among Inpatient Population in the United States. Hepatology communications 3 (3) (2019)
Mehmet Sayiner, Maria Stepanova, Leyla De Avila, Pegah Golabi, Andrei Racila, Zobair M Younossi
Outcomes of Liver Transplant Candidates with Primary Biliary Cholangitis: The Data from the Scientific Registry of Transplant Recipients. Digestive diseases and sciences 65 (2) (2019)
Zobair M Younossi, Maria Stepanova, Youssef Younossi, Pegah Golabi, Alita Mishra, Nila Rafiq, Linda Henry
Epidemiology of chronic liver diseases in the USA in the past three decades. Gut 69 (3) (2019)
Rati Deshpande, Maria Stepanova, Pegah Golabi, Kimberly Brown, Zobair M Younossi
Prevalence, mortality and healthcare utilization among Medicare beneficiaries with Hepatitis C in Haemodialysis units. Journal of viral hepatitis 26 (11) (2019)
Zobair M Younossi, Linda Henry, Janus P Ong, Atsushi Tanaka, Yuichiro Eguchi, Masashi Mizokami, Young Suk Lim, Yock Young Dan, Ming-Lung Yu, Maria Stepanova
Systematic review with meta-analysis: extrahepatic manifestations in chronic hepatitis C virus-infected patients in East Asia. Alimentary pharmacology & therapeutics 49 (6) (2019)
Linda L Henry, Zobair M Younossi
Response to the letter: Hepatitis C screening in opioid epidemics in the United States and societal perspectives. Liver international : official journal of the International Association for the Study of the Liver 38 (7) (2019)
Zobair M Younossi, Radhika P Tampi, Fatema Nader, Issah M Younossi, Rebecca Cable, Manirath Srishord, Andrei Racila
Hypothetical treatment of patients with non-alcoholic steatohepatitis: Potential impact on important clinical outcomes. Liver international : official journal of the International Association for the Study of the Liver 40 (2) (2019)
James M Paik, Rati Deshpande, Pegah Golabi, Issah Younossi, Linda Henry, Zobair M Younossi
The impact of modifiable risk factors on the long-term outcomes of non-alcoholic fatty liver disease. Alimentary pharmacology & therapeutics 51 (2) (2019)
James M Paik, Linda Henry, Leyla De Avila, Elena Younossi, Andrei Racila, Zobair M Younossi
Mortality Related to Nonalcoholic Fatty Liver Disease Is Increasing in the United States. Hepatology communications 3 (11) (2019)
Zobair M Younossi
Editorial: direct-acting antivirals significantly improve quality of life in patients with hepatitis C virus infection-Author's reply. Alimentary pharmacology & therapeutics 47 (4) (2019)
Donghee Kim, George Cholankeril, Andrew A Li, Won Kim, Sean P Tighe, Bilal Hameed, Paul Y Kwo, Stephen A Harrison, Zobair M Younossi, Andrew A Li
Trends in hospitalizations for chronic liver disease-related liver failure in the United States, 2005-2014. Liver international : official journal of the International Association for the Study of the Liver 39 (9) (2019)
Anders H Nyberg, Ekaterina Sadikova, T Craig Cheetham, Kevin M Chiang, Jiaxiao M Shi, Susan L Caparosa, Zobair M Younossi, Lisa M Nyberg
Increased cancer rates in patients with chronic hepatitis C. Liver international : official journal of the International Association for the Study of the Liver 40 (3) (2019)
Leyla de Avila, Ali A Weinstein, J Michael Estep, Michael P Curry, Pegah Golabi, Carey Escheik, Aybike Birerdinc, Maria Stepanova, Lynn Gerber, Zobair M Younossi
Cytokine balance is restored as patient-reported outcomes improve in patients recovering from chronic hepatitis C. Liver international : official journal of the International Association for the Study of the Liver 39 (9) (2019)
Zobair M Younossi, Maria Stepanova, Issah Younossi, Georgios Papatheodoridis, Harry L A Janssen, Kosh Agarwal, Mindie H Nguyen, Ed Gane, Naoky Tsai, Fatema Nader
Patient-reported outcomes in patients chronic viral hepatitis without cirrhosis: The impact of hepatitis B and C viral replication. Liver international : official journal of the International Association for the Study of the Liver 39 (10) (2019)
Pegah Golabi, Natsu Fukui, James Paik, Mehmet Sayiner, Alita Mishra, Zobair M Younossi
Mortality Risk Detected by Atherosclerotic Cardiovascular Disease Score in Patients With Nonalcoholic Fatty Liver Disease. Hepatology communications 3 (8) (2019)
Uchenna Agbim, Yu Jiang, Satish K Kedia, Ashwani K Singal, Andrew A Li, Kalyan Ram Bhamidimarri, David E Bernstein, Stephen A Harrison, Zobair M Younossi, Sanjaya Kumar Satapathy
Impact of Nonmalignant Portal Vein Thrombosis in Transplant Recipients With Nonalcoholic Steatohepatitis. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 25 (1) (2019)
Pegah Golabi, James Paik, Rashmi Reddy, Elisabetta Bugianesi, Gregory Trimble, Zobair M Younossi
Prevalence and long-term outcomes of non-alcoholic fatty liver disease among elderly individuals from the United States. BMC gastroenterology 19 (1) (2019)
Donghee Kim, Andrew A Li, Brandon J Perumpail, Chiranjeevi Gadiparthi, Won Kim, George Cholankeril, Jeffrey S Glenn, Stephen A Harrison, Zobair M Younossi, Andrew A Li
Changing Trends in Etiology-Based and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States. Hepatology (Baltimore, Md.) 69 (3) (2019)
Zobair M Younossi, A Tanaka, Y Eguchi, L Henry, R Beckerman, M Mizokami
Treatment of hepatitis C virus leads to economic gains related to reduction in cases of hepatocellular carcinoma and decompensated cirrhosis in Japan. Journal of viral hepatitis 25 (8) (2018)
Zobair M Younossi, Rohit Loomba, Quentin M Anstee, Mary E Rinella, Elisabetta Bugianesi, Giulio Marchesini, Brent A Neuschwander-Tetri, Lawrence Serfaty, Francesco Negro, Stephen H Caldwell, Vlad Ratziu, Kathleen E Corey, Scott L Friedman, Manal F Abdelmalek, Stephen A Harrison, Arun J Sanyal, Joel E Lavine, Philippe Mathurin, Michael R Charlton, Zachary D Goodman, Naga P Chalasani, Kris V Kowdley, Jacob George, Keith Lindor
Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis. Hepatology (Baltimore, Md.) 68 (1) (2018)
S L Flamm, B Bacon, Michael P Curry, S Milligan, C U Nwankwo, N Tsai, Zobair M Younossi, N Afdhal
Real-world use of elbasvir-grazoprevir in patients with chronic hepatitis C: retrospective analyses from the TRIO network. Alimentary pharmacology & therapeutics 47 (11) (2018)
Zobair M Younossi, Rohit Loomba, Mary E Rinella, Elisabetta Bugianesi, Giulio Marchesini, Brent A Neuschwander-Tetri, Lawrence Serfaty, Francesco Negro, Stephen H Caldwell, Vlad Ratziu, Kathleen E Corey, Scott L Friedman, Manal F Abdelmalek, Stephen A Harrison, Arun J Sanyal, Joel E Lavine, Philippe Mathurin, Michael R Charlton, Naga P Chalasani, Quentin M Anstee, Kris V Kowdley, Jacob George, Zachary D Goodman, Keith Lindor
Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology (Baltimore, Md.) 68 (1) (2018)
Zobair M Younossi
Reply. Hepatology (Baltimore, Md.) 68 (1) (2018)
Omer Shahab, Rakesh Biswas, James Paik, Haley Bush, Pegah Golabi, Zobair M Younossi
Among Patients With NAFLD, Treatment of Dyslipidemia Does Not Reduce Cardiovascular Mortality. Hepatology communications 2 (10) (2018)
Andrew A Li, Rachel Beckerman, Zobair M Younossi
Reply. Hepatology (Baltimore, Md.) 67 (1) (2018)
James Paik, Pegah Golabi, Zahra Younoszai, Alita Mishra, Gregory Trimble, Zobair M Younossi
Chronic kidney disease is independently associated with increased mortality in patients with nonalcoholic fatty liver disease. Liver international : official journal of the International Association for the Study of the Liver 39 (2) (2018)
Zobair M Younossi, Maria Stepanova, Linda Henry, Kwang-Hyub Han, Sang Hoon Ahn, Young-Suk Lim, Wan-Long Chuang, Jia-Horng Kao, Nguyen Kinh, Ching Lung Lai, Man-Fung Yuen, Henry Lik-Yuen Chan, Wei Lai
The effect of interferon-free regimens on health-related quality of life in East Asian patients with chronic hepatitis C. Liver international : official journal of the International Association for the Study of the Liver 38 (7) (2018)
Zobair M Younossi, Maria Stepanova, Eric Lawitz, Michael Charlton, Rohit Loomba, Robert P Myers, Mani Subramanian, John G McHutchison, Zachary Goodman
Improvement of hepatic fibrosis and patient-reported outcomes in non-alcoholic steatohepatitis treated with selonsertib. Liver international : official journal of the International Association for the Study of the Liver 38 (10) (2018)
Zobair M Younossi
The epidemiology of nonalcoholic steatohepatitis. Clinical liver disease 11 (4) (2018)
Zobair M Younossi
The efficacy of new antiviral regimens for hepatitis C infection: Evidence from a systematic review. Hepatology (Baltimore, Md.) 67 (3) (2018)
Zobair M Younossi, Maria Stepanova, Linda Henry, Kwang-Hyub Han, Sang Hoon Ahn, Young Suk Lim, Wan-Long Chuang, Jia-Horng Kao, Kinh V Nguyen, Ching Lung Lai, Henry Lik Yuen Chan, Lai Wei
Sofosbuvir and ledipasvir are associated with high sustained virologic response and improvement of health-related quality of life in East Asian patients with hepatitis C virus infection. Journal of viral hepatitis 25 (12) (2018)
Zobair M Younossi, Arian Afendy, Maria Stepanova, Andrei Racila, Fatema Nader, Rachel Gomel, Ricky Safer, William R Lenderking, Anne Skalicky, Leah Kleinman, Robert P Myers, G Mani Subramanian, John G McHutchison, Cynthia Levy, Christopher L Bowlus, Kris Kowdley, Andrew J Muir
Development and validation of a primary sclerosing cholangitis-specific patient-reported outcomes instrument: The PSC PRO. Hepatology (Baltimore, Md.) 68 (1) (2018)
Mehmet Sayiner, Brian Lam, Pegah Golabi, Zobair M Younossi
Advances and challenges in the management of advanced fibrosis in nonalcoholic steatohepatitis. Therapeutic advances in gastroenterology 11 (2018)

Zobair M Younossi.css-eqlu8i{font-size:small;padding-left:4px;} (Z Younossi, Z M Younossi, Zobair Younossi)

Publication Activity (10 Years)

Top Topics

Top Venues

Zobair M Younossi (Z Younossi, Z M Younossi, Zobair Younossi)